Plain-English translation of NCT06684652 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Prostate Cancer research guide โThis study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a simpler prostate biopsy approach โ using fewer tissue samples โ works just as well as the standard approach for detecting significant prostate cancer. Researchers want to know if reducing the number of samples taken during the biopsy can maintain accuracy while reducing pain, complications, and recovery time for patients.
Current prostate biopsy procedures take many tissue samples to catch cancer, but more samples mean more pain, bleeding, and infection risk. Recent studies suggest that fewer, more targeted samples might be just as effective, but doctors need stronger evidence before changing standard practice.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to receive one of two biopsy techniques. Both involve an MRI-guided procedure where your doctor takes small tissue samples from the suspicious area in your prostate โ one group receives 9 total samples (3 targeted + 6 standard), while the other receives 15 total samples (3 targeted + 12 standard). After the biopsy, researchers will follow up to check for any complications and compare how well each approach detected cancer.
AI-generated summary from trial data ยท Jun 3, 2026 ยท Not medical advice
China